11/20/2024
11:54 AM | HCW Biologics (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
11/18/2024
6:00 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
4:25 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
3:35 PM | HCW Biologics (Filer)
| Form 8-K/A | |
08/14/2024
3:45 PM | HCW Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
3:40 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:35 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
07/18/2024
6:00 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
3:30 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
3:56 PM | HCW Biologics (Issuer)
Winer Gary M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:57 PM | Greene Rick S. (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:33 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
3:36 PM | HCW Biologics (Filer)
| Form ARS/A | |
05/15/2024
4:21 PM | HCW Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2024
3:45 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
3:35 PM | HCW Biologics (Filer)
| Form 10-K/A | |
05/01/2024
4:21 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
6:40 AM | HCW Biologics (Filer)
| Form DEFA14A | |
04/26/2024
6:30 AM | HCW Biologics (Filer)
| Form DEF 14A | |
04/26/2024
6:30 AM | HCW Biologics (Filer)
| Form ARS | |
04/01/2024
3:31 PM | HCW Biologics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/01/2024
3:15 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
3:27 PM | HCW Biologics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/22/2024
1:19 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
1:20 PM | Flowers Lee (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
1:21 PM | GARRETT SCOTT T (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
1:22 PM | Giles Lisa M. (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
1:23 PM | Greene Rick S. (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
1:24 PM | HCW Biologics (Issuer)
Wong Hing C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:39 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/12/2024
6:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
